All individual trials at Leonard-Meron Biosciences, Inc.

0 out of 1

0.0%

$115,690

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
overdue	Leonard-Meron Biosciences, Inc.	NCT02901717	Efficacy and Safety of Mino-Lok Therapy (MLT) in Combination With Systemic Antibiotics in the Treatment of Catheter-Related or Central Line-Associated Bloodstream Infection	2022-12-31	40

Download this data